TetraKit Technologies (2021) is a spin-off company originating from the University of Copenhagen (KU).
Our mission is to revolutionize theranostic agent development through our unique chemistry - The TetraKit Platform. It allows for one-fits-all radiolabeling of most targeting vectors with optimal diagnostic and therapeutic radionuclides. We develop both, our core platform technology, as well as proprietary novel theranostic radiopharmaceuticals based on our platform. This technology is based on the latest advancements in click chemistry and radiolabeling techniques coming from our laboratories.
We are interested in partnerships to combine our radiolabeling platform with emerging targeting vectors.
Company Details
- Employees
- 11
- Founded
- -
- Address
- København N, Hovedstaden 2200, Dk
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://tetrakit.com
- Keywords
- Radiopharmaceuticals, Nuclear Medicine, Click Chemistry, Drug Development, Medicinal Chemistry.
- HQ
- København N, Hovedstaden
Tetrakit Technologies Questions
Tetrakit Technologies's website is http://tetrakit.com
Tetrakit Technologies's LinkedIn profile is https://dk.linkedin.com/company/tetrakit
Tetrakit Technologies has
11 employees.
View email and phone details for 11
employees at Tetrakit Technologies.
Tetrakit Technologies's industry is
Biotechnology Research
Tetrakit Technologies's top competitors are
Glioray,
Akiram Therapeutics,
Triptobio,
Novonesis,
Ousia Pharma,
3b Pharmaceuticals Gmbh,
Solid Therapeutics,
Symphogen,
Prett,
Gubra.
Tetrakit Technologies's categories are Biotechnology Research
Tetrakit Technologies's founding year is 2021
